Table 4 Overall survival of the studied AML patients
From: Interleukin-4 gene intron 3 VNTR polymorphism in adult acute myeloid leukemia
Groups | Total N | N of events | OS (months) | 95% CI | Survival at (%) months | Log Rank Test | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Median | SE | Lower | Upper | 3 months (%) | 6 months (%) | 12 months (%) | X2 | P value | |||
P1P1 and P1P2 | 26 | 14 | 3 | 0.573 | 1.876 | 4.124 | 61.50 | 44.40 | 44.40 | 0.399 | 0.527 |
P2P2 | 24 | 12 | 12 | 4.088 | 3.987 | 20.013 | 66.70 | 57.10 | 38.10 | ||